Drugs / Tetronine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02222532 | Jun 2013 → May 2015 | postoperative ventricular dysfunction | National Cardiovascular Center Harapan Kita Hospital Indonesia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetronine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02222532 ↗ |
| Known as | Sodium Liothyronine | “Tetronine (Sodium Liothyronine) for Infants & Children Undergoing Cardiopulmonary Bypass in a Middle Income Nation (OTICC Study)” NCT02222532 ↗ |
| Route | Other | “was administered via nasogastric tube every 6 h for 60 h” PMID 34851445 ↗ Dec 2021 |